MY127290A
(en )
2006-11-30
New use of flibanserin
PL367277A1
(en )
2005-02-21
Methods of making sustained release formulations of oxymorphone related applications
EP1462134A4
(en )
2010-03-31
Administration instrument for medical use
DE60112974D1
(en )
2005-09-29
Carbolinderivate
EA200301165A1
(en )
2004-06-24
Drug on the basis of oxycodone
GB0226931D0
(en )
2002-12-24
Chemical compounds
YU71901A
(en )
2005-07-19
NOVEL MEDICAMENT COMPOSITIONS, BASED ON ANTICHOLINERGICALLY EFFECTIVE COMPOUNDS AND beta-MIMETICS
AU2002341931A1
(en )
2003-05-19
Patient directed therapy management
GB0111523D0
(en )
2001-07-04
Chemical compounds
GB0128108D0
(en )
2002-01-16
Therapeutic use
DE60216233D1
(en )
2007-01-04
Carbolinderivate
PT998287E
(en )
2003-09-30
USES OF LEVOBUPIVACAINE
ZA200303037B
(en )
2003-11-12
Herbal pharmaceutical composition for treatment of HIV/Aids patients.
ZA987140B
(en )
1999-03-09
Treatment of attention deficit disorders
TW200508199A
(en )
2005-03-01
Novel compound
SG162614A1
(en )
2010-07-29
Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
MXPA03001081A
(en )
2003-10-15
Anti-inflammatory medicament.
CY1105317T1
(en )
2010-03-03
USE OF 6-DIMETHYLAMINOMETHYL-1-PHENYL-CYCLOHEXANE SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF URINARY INCONTINENCE
CY1105142T1
(en )
2009-11-04
USE OF 6-DIMETHYLAMINOMETHYL-1-PHENYL-CYCLOHEXANE SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF URINARY INCONTINENCE
AU2003303217A8
(en )
2004-07-14
Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
IL158186A0
(en )
2004-03-28
Pharmaceutically active compounds and methods of use
UA43619A
(en )
2001-12-17
betatiron as an antihypertensive prolonged drug of a new generation
AU2003281257A8
(en )
2004-01-23
A novel use of rapamycin and structural analogues thereof
SI1458376T1
(en )
2007-06-30
Darifenacin for use in the treatment of urgency induced by overactive bladder
PL367628A1
(en )
2005-03-07
Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia